OBJECTIVE: To examine whether factors related to the patient or her treatment influence asthma severity during pregnancy. METHODS: Symptom and medication data were collected by in-person and telephone interviews. Women were recruited before 24 weeks of gestation through private obstetricians and hospital clinics. Eight hundred seventy-two women had physician-diagnosed asthma, 686 were active asthmatics, and 641 with complete data were analyzed. The Global Initiative for Asthma measured severity. Cumulative logistic regression models for repeated measures assessed changes in asthma severity during each month of pregnancy. RESULTS: Two factors had significant and profound effects on the course of asthma: prepregnancy severity and use of medication according to Global Initiative for Asthma guidelines. Although several factors were analyzed (race, age, atopic status, body mass index, parity, fetal sex, and smoking), none were significant risk factors for changes in asthma severity, measured in a clinically important way as a one-step change in Global Initiative for Asthma category. Women with milder asthma received most benefit from appropriate treatment, 62% decreased risk for worsening asthma among those with intermittent asthma (0.38, 95% confidence interval 0.23-0.64) and 52% decreased risk among those with mild persistent asthma (odds ratio 0.48, 95% confidence interval 0.28-0.84). Month or trimester of gestation was not consistently associated with changes in asthma severity. CONCLUSION: Asthma severity during pregnancy is similar to severity in the year before pregnancy, provided patients continue to use their prescribed medication. If women discontinue medication, even mild asthma is likely to become significantly more severe.
OBJECTIVE: To examine whether factors related to the patient or her treatment influence asthma severity during pregnancy. METHODS: Symptom and medication data were collected by in-person and telephone interviews. Women were recruited before 24 weeks of gestation through private obstetricians and hospital clinics. Eight hundred seventy-two women had physician-diagnosed asthma, 686 were active asthmatics, and 641 with complete data were analyzed. The Global Initiative for Asthma measured severity. Cumulative logistic regression models for repeated measures assessed changes in asthma severity during each month of pregnancy. RESULTS: Two factors had significant and profound effects on the course of asthma: prepregnancy severity and use of medication according to Global Initiative for Asthma guidelines. Although several factors were analyzed (race, age, atopic status, body mass index, parity, fetal sex, and smoking), none were significant risk factors for changes in asthma severity, measured in a clinically important way as a one-step change in Global Initiative for Asthma category. Women with milder asthma received most benefit from appropriate treatment, 62% decreased risk for worsening asthma among those with intermittent asthma (0.38, 95% confidence interval 0.23-0.64) and 52% decreased risk among those with mild persistent asthma (odds ratio 0.48, 95% confidence interval 0.28-0.84). Month or trimester of gestation was not consistently associated with changes in asthma severity. CONCLUSION:Asthma severity during pregnancy is similar to severity in the year before pregnancy, provided patients continue to use their prescribed medication. If women discontinue medication, even mild asthma is likely to become significantly more severe.
Authors: Rachel Enriquez; Pingsheng Wu; Marie R Griffin; Tebeb Gebretsadik; Ayumi Shintani; Ed Mitchel; Kecia N Carroll; Tina V Hartert Journal: Am J Obstet Gynecol Date: 2006-05-02 Impact factor: 8.661
Authors: Kecia N Carroll; Marie R Griffin; Tebeb Gebretsadik; Ayumi Shintani; Ed Mitchel; Tina V Hartert Journal: Obstet Gynecol Date: 2005-07 Impact factor: 7.661
Authors: Helen L Kwon; Elizabeth W Triche; Kathleen Belanger; Michael B Bracken Journal: Immunol Allergy Clin North Am Date: 2006-02 Impact factor: 3.479
Authors: Ludmila N Bakhireva; Michael Schatz; Kenneth Lyons Jones; Carey M Tucker; Donald J Slymen; Hillary S Klonoff-Cohen; Louise Gresham; Diana Johnson; Christina D Chambers Journal: J Asthma Date: 2008-06 Impact factor: 2.515
Authors: Michael B Bracken; Elizabeth W Triche; Kathleen Belanger; Audrey Saftlas; William S Beckett; Brian P Leaderer Journal: Obstet Gynecol Date: 2003-10 Impact factor: 7.661
Authors: Michael Schatz; Mitchell P Dombrowski; Robert Wise; Valerija Momirova; Mark Landon; William Mabie; Roger B Newman; John C Hauth; Marshall Lindheimer; Steve N Caritis; Kenneth J Leveno; Paul Meis; Menachem Miodovnik; Ronald J Wapner; Richard H Paul; Michael W Varner; Mary Jo O'Sullivan; Gary R Thurnau; Deborah L Conway Journal: J Allergy Clin Immunol Date: 2004-06 Impact factor: 10.793
Authors: Michael Schatz; Mitchell P Dombrowski; Robert Wise; Elizabeth A Thom; Mark Landon; William Mabie; Roger B Newman; John C Hauth; Marshall Lindheimer; Steven N Caritis; Kenneth J Leveno; Paul Meis; Menachem Miodovnik; Ronald J Wapner; Richard H Paul; Michael W Varner; Mary Jo O'sullivan; Gary R Thurnau; Deborah Conway; Donald McNellis Journal: J Allergy Clin Immunol Date: 2003-08 Impact factor: 10.793
Authors: Shao Lin; Jean Pierre W Munsie; Michele L Herdt-Losavio; Erin Bell; Charlotte Druschel; Paul A Romitti; Richard Olney Journal: Am J Epidemiol Date: 2008-04-23 Impact factor: 4.897
Authors: Janneane F Gent; Julie M Kezik; Melissa E Hill; Lisa A McKay; Theodore R Holford; Brian P Leaderer; Michael B Bracken Journal: Eur Respir J Date: 2014-12-23 Impact factor: 16.671
Authors: Freddy J K Toloza; Sarah E Theriot; Naykky M Singh Ospina; Sameen Nooruddin; Brooke Keathley; Stacey M Johnson; Nalin Payakachat; Elena Ambrogini; Rene Rodriguez-Gutierrez; Derek T O'Keeffe; Juan P Brito; Victor M Montori; Nafisa K Dajani; Spyridoula Maraka Journal: Thyroid Date: 2021-01-19 Impact factor: 6.568